An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial (Q34668638)

3 August 2017

An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial (English)

1 reference

3 August 2017

0 references

0 references

Habibollah Esmaily

1

0 references

Amirhossein Sahebkar

2

object named as

Amirhossein Sahebkar

1 reference

3 August 2017

Mehrdad Iranshahi

3

1 reference

3 August 2017

Shiva Ganjali

4

1 reference

3 August 2017

Akram Mohammadi

5

1 reference

3 August 2017

Gordon Ferns

6

1 reference

3 August 2017

Majid Ghayour-Mobarhan

7

1 reference

3 August 2017

17 March 2015

1 reference

Chinese Journal of Integrated Traditional and Western Medicine

3 August 2017

1 reference

3 August 2017

21

1 reference

3 August 2017

332-338

1 reference

3 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s11655-015-2160-z

3 August 2017

0 references

cites work

Associations between anxiety, depression, and the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Growth inhibition and apoptosis inducing mechanisms of curcumin on human ovarian cancer cell line A2780.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Effect of curcumin on the gene expression of low density lipoprotein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Molecular mechanisms for curcumin benefits against ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Recent advances in pharmacotherapy for hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Curcumin--from molecule to biological function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Potentials of curcumin as an antidepressant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Curcumin as "Curecumin": from kitchen to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Oxidative damage in mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Aging: a theory based on free radical and radiation chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Oxidative stress in anxiety and comorbid disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Inflammation and endothelial dysfunction during aging: role of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

21 January 2018

Inflammation in anxiety

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

The serotonin-1A receptor in anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

The comparative efficacy of buspirone and diazepam in the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Pindolol augmentation of antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Antidepressant activity of aqueous extracts of Curcuma longa in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11655-015-2160-Z

Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia

21 January 2018

1 reference

12 December 2020

An inventory for measuring clinical anxiety: psychometric properties

1 reference

12 December 2020

Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells

1 reference

12 December 2020

Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial

1 reference

12 December 2020

Innovative approaches for the development of antidepressant drugs: current and future strategies

1 reference

12 December 2020

Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features

1 reference

12 December 2020

10.1007/S11655-015-2160-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference